Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New GLP-1 Medication Lowers A1c Six Months after Treatment Stopped Posted: Sunday, February 07, 2010

Transition Therapeutics announces results of a Phase 2 study of TT-223 (GLP-1 Cpd + Gastrin) in Type 2 diabetes patients. The results show that beta-cells can possibly be generated and/or restored. After a 10 week trial the drug was stopped and 6 months later, the A1c had dropped by 1.13 points.

Insulin Treatment as Safe and as Effective as Triple Oral Therapy Posted: Sunday, February 07, 2010

A study has compared two intensive therapies to lower blood glucose levels in patients with newly diagnosed Type 2 diabetes. The findings reveal the efficacy and safety of both insulin and triple oral therapy.

New First in Class Treatment Shows Significant Improvements in Glucose Lowering Posted: Sunday, February 07, 2010

The study showed positive results from a recently completed Phase 2 study of LX4211 in patients with Type 2 diabetes.

Protein New Target for Obesity, Diabetes Therapies Posted: Sunday, January 31, 2010

Molecule regulates flip of a metabolic switch. A little bit of stress might be just what the doctor ordered to combat obesity and diabetes.

New Breath Sensor Could Help Combat Diabetes Posted: Sunday, January 31, 2010

A tiny new sensor could provide fresh, inexpensive diagnosis and treatment methods for people suffering from a variety of diseases.

Changes in the Position of Insulin Pumps Significantly Impacts Accuracy Posted: Sunday, January 31, 2010

Researchers have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates.

Novo Nordisk receives US approval for Victoza® Posted: Tuesday, January 26, 2010

Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes.

JDRF Artificial Pancreas Project Going Forward Posted: Sunday, January 24, 2010

RF forms partnership with Animas to develop first-generation automated system for managing Type 1 diabetes.

Fear of Hypoglycemia in Parents of Children with Type 1 Diabetes Associated with Poor Control Posted: Sunday, January 24, 2010

The association between a higher level of hypoglycemic-related fear and parental emotional distress and poorer glycemic control in the child emphasizes the need for programs to support and guide parents.

Economic Burden of Diabetes Tops $218B and Going Higher Posted: Sunday, January 24, 2010

Medical costs and reduced work productivity associated with diabetes cost the U.S. $218 billion in 2007, researchers said.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.